by rss feed | Oct 22, 2026 | News Feeds
INmune Bio Inc. (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that it has entered into a Master Services Agreement with Uniphar Durbin Ireland Limited (“Uniphar”) establishing a scalable framework to...
by rss feed | Oct 22, 2026 | News Feeds
Researchers from the University of California San Diego will join a collaboration as part of a federal award of up to $41 million to launch a national effort aimed at accelerating the search for treatments that could prevent or slow Alzheimer's disease. Read Original...
by rss feed | Oct 22, 2026 | News Feeds
Current Good Manufacturing Practice (GMP) standards for cell therapies assess identity, viability, sterility, and genetic stability. For extracellular vesicle (EV) products, Minimal Information for Studies of Extracellular Vesicles (MISEV2023) guidance adds particle...
by rss feed | Oct 22, 2026 | News Feeds
Patients who depend on long-term intravenous catheters for chemotherapy, hemodialysis, intravenous nutrition and other essential therapies face an ongoing risk of catheter-related bloodstream infections, a potentially life-threatening complication that can be...
by rss feed | Oct 22, 2026 | News Feeds
A free, online program developed by University of Colorado Boulder researchers has been shown to reduce risk of depression relapse by double digits among new moms and moms-to-be with a history of depression. Read Original...
by rss feed | Oct 22, 2026 | News Feeds
Cardiac events account for nearly half of all on-duty firefighter deaths in the U.S.—a proportion that has steadily increased over the past three decades, according to a Cedars-Sinai Health Sciences University study. Read Original...